[1] Kent JN, Coplan JD, Gorman JM. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiarty,1998,44:812-824
[2] Gorman JM, Kent JM.SSRIS and SNRIS:Broad spectrum of efficacy beyond major depression.J Clin Psychiatry, 1990,60(Supp14):33-38
[3] 杨德森.神经衰弱研究现状.中华精神科学会神经症与应激相关疾病会议论文集,1999,27-30
[4] Brawman-Mintzer 0,Lydirard RB. Biological basis of generalized anxiety disorder.J Clin Psychiatry,1997,58(Srpp13):16-25
[5] Connor KM,Davidson JRT. Generalized anxiety disorder: Neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry,1998,44:1286-1294
[6] Ballenger JC,Wheadon DE, Steiner M, et al. Double-blind fixed-dose placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry,1998,155:36-42
[7] Oehrberg S,Christiansen PE,Behnke K,et al .Paroxetine in the treatment of panic disorder:A randomised double-blind,placebo-controlled study Br. J Psychiatry,1995,167:374-379
[8] Stein MB, Chartier Mj,Hazen AL,et al.Paroxetine in the treament of generalized social phobia:Open-label treatment and double-blind lacebo-controlled dscontinuation.J clin Psychopharmacol,1996,16:218-222
[9] Rocca P,Fonzo V,Scotta M,et al.Paroxetine efficacy in the treatment of generalized anxiety disorer. Acta Psychiatr Scand ,1997,95:444-450
[10] 邹冈.基础神经药理学.北京:科学出版社,1998.177-192
|